JiaLei Tang has investment, executive and board experience across a range of industries including finance, real estate, hospitality, pharmaceuticals and technology; as well as across many geographies and jurisdictions including Singapore, the US and China.
In the real estate sector, Ms Tang is involved in the evaluation, acquisition and planning of sea port terminal real estate, the development of the new UBS Singapore headquarters and the 1468-unit Parc Clematis residential complex in Singapore. Since 2019, she has been the chief executive officer of Silver City Properties, LLC, a residential property investment and management company in the US which owns and manages properties in New York. In the same year, Ms Tang took on the role as director at Ariva Hospitality, a hospitality management company, directing its rebranding and operations with a focus on sustainability while overseeing its expansion plans into the fund space.
Ms Tang joined the board of TauRx Pharmaceuticals in 2019, whose drug for therapeutic treatment of Alzheimer's Disease is in its phase III trials and will seek FDA, EMA and NMPA approval upon successful results. She also handles the communication and strategic planning for the family office's philanthropy including support for education, the Olympic movement, refugee relief and healthcare.
Ms Tang is pursuing the company directors course from the Australian Institute of Company Directors, and a Master in Urban Planning at Harvard University in September 2021 (with graduation due in 2023).
